Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(31 sites)
United States
City of Hope, Duarte, California University of California, San Francisco (UCSF), San Francisco, California Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Santa Monica, California Stanford Cancer Institute (SCI), Stanford, California Massachusetts General Hospital, Boston, Massachusetts Regional Cancer Care Associates LLC (RCCA) - Freehold Location, Freehold, New Jersey Regional Cancer Care Associates LLC ? Howell Division, Howell Township, New Jersey Levine Cancer Institute, Charlotte, North Carolina Thomas Jefferson University Hospital, Philadelphia, Pennsylvania University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania West Cancer Center, Germantown, Tennessee Australia
Flinders Medical Centre, Bedford Park, South Australia Peninsula Health-Frankston Hospital, Frankston, Victoria Peter Maccallum Cancer Centre, Melbourne, Victoria Linear Clinical Research Limited, Nedlands, Western Australia Israel
Shaare Zedek Medical Center, Jerusalem, Jerusalem Rambam Medical Center, Haifa Hadassah Ein Karem Hospital, Jerusalem The Chaim Sheba Medical Center, Ramat Gan Tel Aviv Sourasky Medical Center, Tel Aviv Assuta Medical Centers, Tel Aviv South Korea
National Cancer Center, Goyang-si Samsung Medical Center, Seoul Seoul National University Hospital, Seoul Asan Medical Center, Seoul Severance Hospital, Seoul Spain
Hospital Universitario Vall d Hebron, Barcelona Hospital Universitario Ramón y Cajal, Madrid Centro Integral Oncológico Clara Campal Ensayos Clínicos START, Madrid Hospital Clinico Universitario de Valencia, Valencia